Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

This study is currently recruiting participants.
Verified October 2009 by University of Leipzig
Sponsor:
Collaborators:
Celgene Corporation
Mundipharma Pte Ltd.
Amgen
Information provided by:
University of Leipzig
ClinicalTrials.gov Identifier:
NCT01002703
First received: October 23, 2009
Last updated: August 11, 2011
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)